We are live on
!
Find out more
RBFC
Roman Butler Fullerton & Co Portfolio holdings
AUM
$419M
1-Year Est. Return
31.15%
This Fund
S&P 500
This Quarter
Est. Return
+8.42%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$7.72M
(+4%)
Cap. Flow
+$5.29M
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
28.37%
Holding
211
New
21
Increased
106
Reduced
54
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.74M |
| 2 |
Microsoft
MSFT
|
+$1.58M |
| 3 |
NVIDIA
NVDA
|
+$1.15M |
| 4 |
Cigna
CI
|
+$1.05M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.95M |
| 2 |
Humana
HUM
|
+$1.3M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$1.28M |
| 4 |
UnitedHealth
UNH
|
+$1.19M |
| 5 |
Boeing
BA
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.92% |
| 2 | Healthcare | 12.1% |
| 3 | Financials | 8.97% |
| 4 | Consumer Staples | 8.04% |
| 5 | Consumer Discretionary | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
201
Neurocrine Biosciences
NBIX
$16.1B
| – | – |
-11,864
| Closed | -$1.28M |
|
202
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
| – | – |
-8,833
| Closed | -$226K |
|
203
Schwab International Equity ETF
SCHF
$69.2B
| – | – |
-35,612
| Closed | -$618K |
|
204
Schwab US Large-Cap Growth ETF
SCHG
$62.6B
| – | – |
-45,740
| Closed | -$667K |
|
205
Schwab US REIT ETF
SCHH
$11.2B
| – | – |
-12,676
| Closed | -$261K |
|
|
SCHV
206
Schwab US Large-Cap Value ETF
SCHV
$16.2B
| – | – |
-38,610
| Closed | -$880K |
|
207
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| – | – |
-19,908
| Closed | -$468K |
|
208
Super Micro Computer
SMCI
$23.1B
| – | – |
-27,890
| Closed | -$237K |
|
209
Steel Dynamics
STLD
$37.7B
| – | – |
-7,295
| Closed | -$804K |
|
210
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
| – | – |
-2,200
| Closed | -$251K |
|
211
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.3B
| – | – |
-1,859
| Closed | -$264K |
|
Similar funds
MMG
DBRC
CMHI
PIMC
VIS
AI
TI
MCM
Roman Butler Fullerton & Co's Q1 2023 Portfolio in Review
As of Q1 2023, Roman Butler Fullerton & Co held 211 positions worth $201M, up 4% from $193M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Roman Butler Fullerton & Co's Q1 2023 filing shows 21 new, 106 increased, 54 reduced and 22 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 4,734 shares worth $1.05M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.95M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Roman Butler Fullerton & Co's largest Q1 2023 buy was Pioneer Natural Resource Co.: 4,734 shares worth $1.05M.
- Roman Butler Fullerton & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $2.74M increase.
- Roman Butler Fullerton & Co's biggest Q1 2023 reduction was UnitedHealth, cutting an estimated $1.19M.
- Roman Butler Fullerton & Co fully exited iShares Russell 1000 Value ETF in Q1 2023, selling an estimated $2.95M.
- Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $201M portfolio in Q1 2023.
- Roman Butler Fullerton & Co opened 21 new positions and closed 22 in Q1 2023.
- Roman Butler Fullerton & Co's portfolio value rose 4% quarter-over-quarter to $201M.
Based on Roman Butler Fullerton & Co's 13F filing for Q1 2023, filed 27 Apr 2023.